Jobst Lab Overview

Conrad Jobst Portrait

The University of Michigan Medical School and The Toledo Hospital formed Jobst Vascular Center (JVC) in response to a generous and purposeful endowment from the late Caroline Jobst. Her gift, in memory of her husband Conrad, continues to support the Conrad Jobst Vascular Research Laboratories in Ann Arbor, the Jobst Vascular Institute in Toledo, the Conrad Jobst Lectureship, a vascular research fellowship program and other activities in both areas.

The Conrad Jobst Vascular Research Laboratories on the campus of the University of Michigan are state-of-the-art research facilities occupying 4,900 square feet in the North Campus Research Complex. There are a number of core units that make-up the Jobst Laboratories including a molecular, hematology and cell biology unit, and a small animal operating facility. Jobst investigators are funded by the National Institutes of Health along with other external sponsors, including a prestigious vascular training grant. Not only is cutting-edge research performed in the Jobst Laboratories, but they serve to train academic vascular surgeons of the future. The major topics of research include venous thrombosis, vascular inflammation, thrombus resolution, traumatic injury, nephropathy, abdominal aneurysms, and medical device testing. 

Located on the campus of The Toledo Hospital, JVI is an active treatment center for patients with vascular disease, providing comprehensive clinical care for the full range of vascular problems. The IACVL-accredited Jobst Vascular Laboratory performs over 18,000 noninvasive examinations annually. JVI has a two-year ACGME-accredited vascular surgery residency program which accepts two surgeons each year to prepare them for a career in vascular surgery. This educational program is integrated with the academic vascular program at the University of Michigan. The clinical research department is one of the largest and most comprehensive clinical vascular research units in the country. All areas of vascular disease are studied and all phases of clinical research are performed. JVI is involved in three NIH research protocols, three therapeutic angiogenesis studies, trials evaluating improved treatment for acute deep venous thrombosis and pulmonary embolism, direct clot dissolution in patients with acute arterial and graft thrombosis, studies evaluating improved cholesterol and blood pressure control and numerous investigator-initiated studies. The ultimate goal is improved patient care through the generation of new knowledge, presentation of findings at regional and national symposia and publication in peer-reviewed journals.